Compounds > phenylalanyl-prolyl-arginine-chloromethyl ketone
Page last updated: 2024-09-03

phenylalanyl-prolyl-arginine-chloromethyl ketone and ximelagatran

phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with ximelagatran in 1 studies

Compound Research Comparison

Studies
(phenylalanyl-prolyl-arginine-chloromethyl ketone)		Trials
(phenylalanyl-prolyl-arginine-chloromethyl ketone)		Recent Studies (post-2010)
(phenylalanyl-prolyl-arginine-chloromethyl ketone)		Studies
(ximelagatran)		Trials
(ximelagatran)		Recent Studies (post-2010) (ximelagatran)
1914233997542

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bode, C; Darius, H; Diehm, C; Encke, A; Gulba, DC; Haas, S; Hacke, W; Puhl, W; Quante, M; Riess, H; Scharf, R; Schellong, S; Schrör, T; Schulte, KL; Tebbe, U; Van Aken, H1

Reviews

1 review(s) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and ximelagatran

ArticleYear
Anticoagulation: the present and future.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2001, Volume: 7, Issue:3

    Topics: Administration, Oral; Amino Acid Chloromethyl Ketones; Anticoagulants; Arginine; Azetidines; Benzylamines; Binding Sites; Biological Availability; Blood Coagulation; Comorbidity; Coumarins; Drug Design; Embolism; Female; Forecasting; Glycine; Guanidines; Heart Diseases; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Neoplasms; Pipecolic Acids; Pregnancy; Pregnancy Complications, Hematologic; Prodrugs; Safety; Serine; Stroke; Sulfonamides; Thrombin; Thrombophilia; Thrombosis

2001